발행물

전체 논문

105

31

Jee H#, Park E, Hur K, Kang M, Kim Y#. (2022). High-intensity Aerobic Exercise Suppresses Cancer Growth by Regulating Skeletal Muscle-derived Oncogenes and Tumor Suppressors. Front Mol Biosci 9, 818470.
Jee H#, Park E, Hur K, Kang M, Kim Y#
Front Mol Biosci, 2022

32

Park S*, Ku J*, Lee S-M, Hwang H, Lee N, Kim H, Yoon K-J, Kim Y#, Choi SQ#. (2022). Potential toxicity of inorganic ions in particulate matter: Ion permeation in lung and disruption of cell metabolism. Sci. Total Environ 824, 153818.
Park S*, Ku J*, Lee S-M, Hwang H, Lee N, Kim H, Yoon K-J, Kim Y#, Choi SQ#
Sci. Total Environ, 2022

33

Yoon J*, Lee M-S*, Ali AA, Oh YR, Choi YS, Kim S, Lee N, Jang SG, Ahamad N, Kwok S-K, Hyon JY, Cha S, Lee YJ#, Im SG#, Kim Y#. Targeting mitochondrial double-stranded RNAs ameleiorates autoimmune characteristics of Sjogren's syndrome. bioRxiv (Published as Yoon et al. Mol Ther Nucleic Acids 2022)
Yoon J*, Lee M-S*, Ali AA, Oh YR, Choi YS, Kim S, Lee N, Jang SG, Ahamad N, Kwok S-K, Hyon JY, Cha S, Lee YJ#, Im SG#, Kim Y#
bioRxiv, 2021

34

Na H, Kang B-H, Ku J, Kim Y, Jeong K-H. (2021). On-chip Paper Electrophoresis for Ultrafast Screening for Infectious Diseases. Biochip J 15, 305-311.
Na H, Kang B-H, Ku J, Kim Y, Jeong K-H
Biochip J, 2021

35

Shin S-B, Kim D-H, Kim D-E, Aldonza MBD, Kim Y, Yim H. (2021). Dual Targeting of EGFR with PLK1 Exerts Therapeutic Synergism in Taxane-Resistant Lung Adenocarcinoma by Suppressing ABC Transporters. Cancers 13, 4413.
Shin S-B, Kim D-H, Kim D-E, Aldonza MBD, Kim Y, Yim H
Cancers, 2021

36

Thatayatikom A, Jun I, Bhattacharyya I, Berg K, Lee YJ, Kim Y, Adewumi A, Zhang W, Thatayatikom S, Shah A, Beal C, Modica R, Elder ME, Cha S. (2021). The diagnostic performance of early Sjogren's syndrome autoantibodies in juvenile Sjogren's syndrome: The University of Florida Pediatric Cohort Study. Front immunol 12, 2373.
Thatayatikom A, Jun I, Bhattacharyya I, Berg K, Lee YJ, Kim Y, Adewumi A, Zhang W, Thatayatikom S, Shah A, Beal C, Modica R, Elder ME, Cha S
Front immunol, 2021

37

Aldonza MBD*, Cha J*, Yong I*, Ku J, Lee D, Sinitcyn P, Cho R, Delos Reyes RD, Kim D, Sung H-J, Kim S, Kang M, Ku Y, Park G, Ryu HS, Cho S, Kim TM, Kim P#, Cho JY#, Kim Y#. Widespread multi-targeted therapy resistance via drug-induced secretome fucosylation. bioRxiv (Published as Aldonza et al. in eLife)
Aldonza MBD*, Cha J*, Yong I*, Ku J, Lee D, Sinitcyn P, Cho R, Delos Reyes RD, Kim D, Sung H-J, Kim S, Kang M, Ku Y, Park G, Ryu HS, Cho S, Kim TM, Kim P#, Cho JY#, Kim Y#
bioRxiv, 2021

38

Aldonza MBD, Delos Reyes RD, Kim YS, Ku J, Barsallo AM, Hong J, Lee SK, Ryu HS, Park YK, Cho JY#, Kim Y#. (2021). Chemotherapy confers a conserved secondary tolerance to EGFR inhibition via AXL-mediated signaling bypass. Sci Rep 11, 8016.
Aldonza MBD, Delos Reyes RD, Kim YS, Ku J, Barsallo AM, Hong J, Lee SK, Ryu HS, Park YK, Cho JY#, Kim Y#
Sci Rep, 2021

39

Song J, Kim S, Kim HY, Hur K, Kim Y, Park HG. (2021). A novel method to detect mutation in DNA by utilizing exponential amplification reaction triggered by the CRISPR-Cas9 system. Nanoscale 13, 7193-7201.
Song J, Kim S, Kim HY, Hur K, Kim Y, Park HG
Nanoscale, 2021

40

Ku Y*, Park JH*, Cho R*, Lee Y, Park HM, Kim M, Hur K, Byun S, Liu J, Lee YS, Shum D, Shin DY, Koh Y, Cho JY, Yoon SS, Hong J#, Kim Y#. (2021). Noncanonical immune response to the inhibition of DNA methylation via stabilization of endogenous retrovirus dsRNAs. Proc Natl Acad Sci U S A. 118, e2016289118
Ku Y*, Park JH*, Cho R*, Lee Y, Park HM, Kim M, Hur K, Byun S, Liu J, Lee YS, Shum D, Shin DY, Koh Y, Cho JY, Yoon SS, Hong J#, Kim Y#
Proc Natl Acad Sci U S A., 2021